HVH Precision Analytics has received the Pharma Tech Outlook magazine’s Company of the Year recognition for its work in the life sciences and pharmacy field as an analytics tool and services provider.
HVH was named to the magazine’s list of top 10 analytics platforms providers selected by a panel of CEOs, chief information officers, venture capitalists, analysts and the publication’s editorial board, Havas Health & You said Thursday.
HVH is a joint venture formed by Havas Health and Vencore, which now operates as part of Perspecta, in 2016 to offer data and predictive analytics tools designed to speed up diagnosis and treatment of patients and identify potential clinical trial candidates.
“I … would like to congratulate the HVH team on this remarkable achievement,” said Mac Curtis, Perspecta president and CEO.
Curtis, a four-time Wash100 recipient, added that it is rewarding to see Perspecta’s efforts and experience as a data analytics platforms provider to government clients transpire in the health care sector through HVH that works to help improve the “lives of patients that would otherwise be undiagnosed.”
HVH’s platform uses machine learning, predictive analytics and artificial intelligence to collect and analyze large amounts of disparate health care data to help biopharma companies generate insights for patient identification.